BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11932892)

  • 1. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
    Neuschatz AC; DiPetrillo T; Steinhoff M; Safaii H; Yunes M; Landa M; Chung M; Cady B; Wazer DE
    Cancer; 2002 Apr; 94(7):1917-24. PubMed ID: 11932892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.
    Wazer DE; Schmidt-Ullrich RK; Schmid CH; Ruthazer R; Kramer B; Safaii H; Graham R
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):291-9. PubMed ID: 9226315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.
    Cao D; Lin C; Woo SH; Vang R; Tsangaris TN; Argani P
    Am J Surg Pathol; 2005 Dec; 29(12):1625-32. PubMed ID: 16327435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor.
    Wazer DE; Schmidt-Ullrich RK; Ruthazer R; DiPetrillo T; Boyle T; Kanski J; Safaii H
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):885-91. PubMed ID: 10571194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological margin assessment for breast ductal carcinoma in situ: precision and implications.
    Sigal-Zafrani B; Lewis JS; Clough KB; Vincent-Salomon A; Fourquet A; Meunier M; Falcou MC; Sastre-Garau X;
    Mod Pathol; 2004 Jan; 17(1):81-8. PubMed ID: 14657957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-menopausal Status, High Nuclear Grade, Tumor Size >30 mm and Positive Resection Margins Are Predictors of Residual Tumor After Lumpectomy for Ductal Carcinoma In Situ of the Breast.
    Joste M; Mendes V; Tixier S; Palpacuer C; Laviolle B; Leveque J; Ouldamer L
    Anticancer Res; 2015 Jun; 35(6):3471-7. PubMed ID: 26026112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
    Chagpar A; Yen T; Sahin A; Hunt KK; Whitman GJ; Ames FC; Ross MI; Meric-Bernstam F; Babiera GV; Singletary SE; Kuerer HM
    Am J Surg; 2003 Oct; 186(4):371-7. PubMed ID: 14553853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for residual occult disease in shave margins during partial mastectomy.
    Siegel JB; Mukherjee R; Park Y; Cluver AR; Chung C; Cole DJ; Lockett MA; Klauber-DeMore N; Abbott AM
    Breast Cancer Res Treat; 2021 Sep; 189(2):471-481. PubMed ID: 34132936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease.
    Cheng L; Al-Kaisi NK; Gordon NH; Liu AY; Gebrail F; Shenk RR
    J Natl Cancer Inst; 1997 Sep; 89(18):1356-60. PubMed ID: 9308705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
    Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ.
    Howard-McNatt M; Dupont E; Tsangaris T; Garcia-Cantu C; Chiba A; Berger AC; Levine EA; Gass JS; Ollila DW; Chagpar AB;
    J Am Coll Surg; 2021 Apr; 232(4):373-378. PubMed ID: 33346081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of residual disease in repeat excisions for lumpectomies with margins less than 0.1 cm.
    Rodriguez N; Diaz LK; Wiley EL
    Clin Breast Cancer; 2005 Jun; 6(2):169-72. PubMed ID: 16001996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.
    Murphy BL; Boughey JC; Keeney MG; Glasgow AE; Racz JM; Keeney GL; Habermann EB
    Mayo Clin Proc; 2018 Apr; 93(4):429-435. PubMed ID: 29439832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: prognostic significance of reexcision.
    Vapiwala N; Harris E; Hwang WT; Solin LJ
    Cancer J; 2006; 12(1):25-32. PubMed ID: 16613659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.